These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7279315)

  • 1. Eseroline: a new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodents.
    Bartolini A; Renzi G; Galli A; Aiello PM; Bartolini R
    Neurosci Lett; 1981 Sep; 25(2):179-83. PubMed ID: 7279315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence that eseroline possesses morphine-like effects.
    Fürst S; Friedmann T; Bartolini A; Bartolini R; Aiello-Malmberg P; Galli A; Somogyi GT; Knoll J
    Eur J Pharmacol; 1982 Sep; 83(3-4):233-41. PubMed ID: 6293841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine.
    Galli A; Renzi G; Grazzini E; Bartolini R; Aiello-Malmberg P; Bartolini A
    Biochem Pharmacol; 1982 Apr; 31(7):1233-8. PubMed ID: 7092918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of (-)-eseroline with (+)-eseroline and dihydroseco analogues in antinociceptive assays: confirmation of rubreserine structure by X-ray analysis.
    Schönenberger B; Jacobson AE; Brossi A; Streaty R; Klee WA; Flippen-Anderson JL; Gilardi R
    J Med Chem; 1986 Nov; 29(11):2268-73. PubMed ID: 3023611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.
    Hughes J; Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the analgesic effects of galanthamine, a cholinesterase inhibitor.
    Cozanitis DA; Friedmann T; Fürst S
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):229-38. PubMed ID: 6667067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dihydroetorphine on contraction response of guinea pig ileum, mouse, and rabbit vas deferens induced by electric field stimulation in vitro].
    Wang DX; Qin BY
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):420-2. PubMed ID: 1687907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiatelike actions of eseroline, an eserine derivative.
    Jhamandas K; Elliott J; Sutak M
    Can J Physiol Pharmacol; 1981 Mar; 59(3):307-10. PubMed ID: 7194726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loperamide: evidence of interaction with mu and delta opioid receptors.
    Giagnoni G; Casiraghi L; Senini R; Revel L; Parolaro D; Sala M; Gori E
    Life Sci; 1983; 33 Suppl 1():315-8. PubMed ID: 6319884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y; Mazarguil H; Gout R; Cros J
    Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and opioid activity of new fentanyl analogs.
    Girón R; Abalo R; Goicoechea C; Martín MI; Callado LF; Cano C; Goya P; Jagerovic N
    Life Sci; 2002 Jul; 71(9):1023-34. PubMed ID: 12088762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
    Shook JE; Kachur JF; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):848-52. PubMed ID: 3712282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.